BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6805380)

  • 1. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended survival of purified canine islet allografts with heterologous antilymphocyte globulin.
    Kaufman DB; Morel P; Field MJ; Roney M; Condie R; Sutherland DE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):761-3. PubMed ID: 1990682
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function.
    Kaufman DB; Morel P; Condie R; Field MJ; Rooney M; Tzardis P; Stock P; Sutherland DE
    Transplantation; 1991 Jan; 51(1):37-42. PubMed ID: 1987703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet cell transplantation: important factors contributing to optimal pancreatic function.
    Toledo-Pereyra LH; Bandlien KO; Amiel J
    P R Health Sci J; 1987 Aug; 6(2):101-6. PubMed ID: 3118405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of islet cells.
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Surg Gynecol Obstet; 1984 Jan; 158(1):49-56. PubMed ID: 6419360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal subcapsular islet cell transplantation.
    Toledo-Pereyra LH; Bandlien KO; Gordon DA; MacKenzie GH; Reyman TA
    Am Surg; 1985 Dec; 51(12):721-9. PubMed ID: 3000237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to demonstrate a synergistic effect between enhancing serum and ALS in recipients of pancreatic islet allografts.
    Finch DR; Morris PJ
    Transplantation; 1977 Apr; 23(4):386-8. PubMed ID: 405761
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful experimental heart transplantation without immunosuppressive drugs.
    Kline GM; Shen Z; Mohiuddin M; Ruggiero V; Rostami S; DiSesa VJ
    J Heart Lung Transplant; 1993; 12(3):388-93. PubMed ID: 8329408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful intrathymic allografts of porcine pancreatic islets without continuous immunosuppression.
    Kenmochi T; Une S; Miyamoto M; Nakagawa Y; Benhamou PY; Mullen Y
    Transplant Proc; 1995 Feb; 27(1):145-7. PubMed ID: 7878939
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antilymphocyte serum on crude pancreatic islet allograft survival.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful engraftment of autologous and allogeneic islets into the porcine thymus.
    Watt PC; Mullen Y; Nomura Y; Watanabe Y; Brunicardi FC; Anderson C; Zinner MJ; Passaro EP
    J Surg Res; 1994 Apr; 56(4):367-71. PubMed ID: 8152232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
    Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of long-term (1 year) graft survival and metabolic and hormonal changes after intrasplenic canine pancreatic microfragment transplantation.
    Marchetti P; Olack B; Swanson C; Newton M; Scharp DW
    Diabete Metab; 1993; 19(1):17-24. PubMed ID: 8504880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilymphocyte globulin and renal transplantation.
    Tagnon A
    Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of canine islet allograft survival by 15-deoxyspergualin.
    Stephanian E; Lloveras JJ; Sutherland DE; Farney AC; Field MJ; Kaufman DB; Matteson BD; Gores PF
    J Surg Res; 1992 Jun; 52(6):621-4. PubMed ID: 1528039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet allograft prolongation by selective lymphoid irradiation (SLI), culture techniques, and ALG.
    Reemtsma K; Oluwole S; Fawwaz R; Hardy MA
    Transplant Proc; 1981 Mar; 13(1 Pt 2):801-6. PubMed ID: 6791335
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.